The development of 2-acetylphenol-donepezil hybrids as multifunctional agents for the treatment of Alzheimer’s disease
Graphical abstract
Section snippets
Declaration of Competing Interest
The authors declare no competing financial interest.
Acknowledgments
This work was supported in part by the Foundation and Frontier Projects of Nanyang Science and Technology Bureau (2017JCQY020 and 2017 JCQY021). The Special Project of Nanyang Normal University (SYKF2018081 and 2019QN001). The Key Scientific Research Project of Colleges and Universities in Henan Province (NO.20A350006). International Training of High-level Talents in Henan Province in 2019 (NO.17) (Henan Foreign Experts Bureau). Graduate Innovation Fund Project of Nanyang Normal University
References (22)
- et al.
A review on Alzheimer’s disease pathophysiology and its management: an update
Pharmacol Rep
(2015) - et al.
Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease
Bioorg Med Chem Lett
(2017) - et al.
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer’s disease
Eur J Med Chem
(2018) - et al.
Design, synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer’s disease
Eur J Med Chem
(2017) - et al.
Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer’s disease
Eur J Med Chem
(2015) - et al.
Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease
Eur J Med Chem
(2017) - et al.
Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer’s disease
Eur J Med Chem
(2014) - et al.
Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer’s disease
Bioorg Med Chem
(2015) - et al.
Multi-targetable chalcone analogs to treat deadly Alzheimer’s disease: current view and upcoming advice
Bioorg Chem
(2018) - et al.
Multitarget drug design strategy against Alzheimer’s disease: homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties
Bioorg Med Chem
(2017)
High throughput artificial membrane permeability assay for blood-brain barrier
Eur J Med Chem
Cited by (16)
Synthesis and molecular dynamic simulation studies of novel N-(1-benzylpiperidin-4-yl) quinoline-4-carboxamides as potential acetylcholinesterase inhibitors
2021, Journal of Molecular StructureCitation Excerpt :Many tacrine derivatives/hybrids have been designed and synthesized in order to reduce its adverse side effects, while retaining its AChE inhibitory property(1) Donepezil (Fig. 1) is a FDA approved drug for palliative treatment of AD that acts through potent and selective inhibition of AChE [2]. Favorable pharmacokinetic profile and potent AChE inhibition in vivo of donepezil have directed significant research efforts towards development of donepezil analogues as potential therapeutics of AD [2-14]. Quinoline moiety is an important aromatic ring with a broad spectrum of biological activity [15-22].
Insights on synthetic strategies and structure-activity relationship of donepezil and its derivatives
2024, Medicinal Chemistry ResearchChoroba Alzheimera – przegląd substancji leczniczych i ich pochodnych
2024, Farmacja PolskaIn silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases
2023, Current Topics in Medicinal Chemistry
- d
These authors contributed equally.